Xi Chen

Safety and efficacy profile of cyclin‐dependent kinases 4/6 inhibitor palbociclib in cancer therapy: A meta‐analysis of clinical trials

Linghong Guo, Xuelei Ma, Yuanyuan Hu, 2019, Cancer medicine.